ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The Italian drug outsourcing firm Flamma has commissioned a production suite at its facility in Malvern, Pennsylvania, for high-potency active pharmaceutical ingredients (APIs). Flamma acquired the facility in 2019 from Teva Pharmaceutical Industries to establish a manufacturing foothold in the US. The site can produce APIs for early-stage clinical development. The company says it employs 35 people in the US.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X